Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)75-82
JournalAnnals of Neurology
Volume69
Issue number1
DOIs
Publication statusPublished - Jan 2011

Cite this